In last trading session, Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) saw 1.32 million shares changing hands with its beta currently measuring -0.15. Company’s recent per share price level of $1.63 trading at -$0.05 or -2.98% at ring of the bell on the day assigns it a market valuation of $75.92M. That closing price of RVPH’s stock is at a discount of -176.07% from its 52-week high price of $4.50 and is indicating a premium of 63.19% from its 52-week low price of $0.60.
For Reviva Pharmaceuticals Holdings Inc (RVPH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.22 in the current quarter.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) trade information
Upright in the red during last session for losing -2.98%, in the last five days RVPH remained trading in the red while hitting it’s week-highest on Thursday, 02/13/25 when the stock touched $1.63 price level, adding 14.21% to its value on the day. Reviva Pharmaceuticals Holdings Inc’s shares saw a change of -9.94% in year-to-date performance and have moved -12.83% in past 5-day. Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) showed a performance of -18.50% in past 30-days.
In 2025, company’s earnings growth rate is likely to be around 40.26% while estimates for its earnings growth in next 5 years are of 20.47%.
Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH)’s Major holders
WOODLINE PARTNERS LP is the top institutional holder at RVPH for having 1.59 million shares of worth $2.04 million. And as of 2024-06-30, it was holding 5.2129 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 1.03 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.2659 of outstanding shares, having a total worth of $1.31 million.
